QT
ACET icon

Quantbot Technologies’s Adicet Bio ACET Stock Holding History

Quantbot Technologies’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-344
Closed -$12.9K – 1379
2024
Q1 		$12.9K Hold
344
– – ﹤0.01% 1442
2023
Q4 		$10.4K Sell
344
-37
-10% -$807 ﹤0.01% 1457
2023
Q3 		$8.36K Sell
381
-375
-50% -$13.2K ﹤0.01% 1423
2023
Q2 		$29.4K Sell
756
-169
-18% -$14.9K ﹤0.01% 1383
2023
Q1 		$85.2K Buy
+925
New +$116K 0.01% 1134

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Quantbot Technologies's ACET Position: Q2 2024 in Review

Quantbot Technologies sold out of Adicet Bio (ACET) in Q2 2024, closing a stake of 344 shares — an estimated $12.9K sold.

Quantbot Technologies first reported a position in ACET in Q1 2023 and held it in 5 quarters. The position peaked at $85.2K in Q1 2023. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • Quantbot Technologies reported no remaining Adicet Bio position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 344 Adicet Bio shares in Q2 2024, an estimated $12.9K.
  • Quantbot Technologies first reported a position in Adicet Bio in Q1 2023 and held it in 5 quarters.
  • Quantbot Technologies's Adicet Bio position peaked at $85.2K in Q1 2023.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.